These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10627474)

  • 1. Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors.
    Emanuel PD; Snyder RC; Wiley T; Gopurala B; Castleberry RP
    Blood; 2000 Jan; 95(2):639-45. PubMed ID: 10627474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells.
    Mahgoub N; Taylor BR; Gratiot M; Kohl NE; Gibbs JB; Jacks T; Shannon KM
    Blood; 1999 Oct; 94(7):2469-76. PubMed ID: 10498620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R.
    Iversen PO; Rodwell RL; Pitcher L; Taylor KM; Lopez AF
    Blood; 1996 Oct; 88(7):2634-9. PubMed ID: 8839857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor.
    Chan RJ; Leedy MB; Munugalavadla V; Voorhorst CS; Li Y; Yu M; Kapur R
    Blood; 2005 May; 105(9):3737-42. PubMed ID: 15644411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.
    Frankel AE; Lilly M; Kreitman R; Hogge D; Beran M; Freedman MH; Emanuel PD; McLain C; Hall P; Tagge E; Berger M; Eaves C
    Blood; 1998 Dec; 92(11):4279-86. PubMed ID: 9834234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro.
    Ohtsuka Y; Manabe A; Kawasaki H; Hasegawa D; Zaike Y; Watanabe S; Tanizawa T; Nakahata T; Tsuji K
    Blood; 2005 Nov; 106(9):3134-41. PubMed ID: 16046524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth.
    Iversen PO; Emanuel PD; Sioud M
    Blood; 2002 Jun; 99(11):4147-53. PubMed ID: 12010819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile myelomonocytic leukemia.
    Emanuel PD
    Curr Hematol Rep; 2004 May; 3(3):203-9. PubMed ID: 15087069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile chronic myelogenous leukemia: in vitro characterization before and after allogeneic bone marrow transplantation.
    Zecca M; Rosti V; Pinto L; Comoli P; Carrà AM; Prete L; Bonetti F; Pedrazzoli P; Locatelli F; Cazzola M
    Med Pediatr Oncol; 1995 Mar; 24(3):166-70. PubMed ID: 7838038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.
    Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release.
    Oehler L; Foedinger M; Koeller M; Kollars M; Reiter E; Bohle B; Skoupy S; Fritsch G; Lechner K; Geissler K
    Blood; 1997 Feb; 89(4):1147-53. PubMed ID: 9028936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro expansion of CD34(+)CD38(-) cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia.
    Sakashita K; Kato I; Daifu T; Saida S; Hiramatsu H; Nishinaka Y; Ebihara Y; Ma F; Matsuda K; Saito S; Hirabayashi K; Kurata T; Uyen LT; Nakazawa Y; Tsuji K; Heike T; Nakahata T; Koike K
    Leukemia; 2015 Mar; 29(3):606-14. PubMed ID: 25102944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting RAS signaling pathways in juvenile myelomonocytic leukemia.
    Flotho C; Kratz C; Niemeyer CM
    Curr Drug Targets; 2007 Jun; 8(6):715-25. PubMed ID: 17584027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.
    Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM
    Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice.
    Iversen PO; Lewis ID; Turczynowicz S; Hasle H; Niemeyer C; Schmiegelow K; Bastiras S; Biondi A; Hughes TP; Lopez AF
    Blood; 1997 Dec; 90(12):4910-7. PubMed ID: 9389708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Juvenile myelomonocytic leukemias].
    Lachenaud J; Strullu M; Baruchel A; Cavé H
    Bull Cancer; 2014 Mar; 101(3):302-13. PubMed ID: 24691193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of SRC corrects GM-CSF hypersensitivity that underlies juvenile myelomonocytic leukemia.
    Bunda S; Kang MW; Sybingco SS; Weng J; Favre H; Shin DH; Irwin MS; Loh ML; Ohh M
    Cancer Res; 2013 Apr; 73(8):2540-50. PubMed ID: 23400592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myelomonocytic leukemia requires granulocyte-macrophage colony-stimulating factor for growth in vitro and in vivo.
    Ramshaw HS; Bardy PG; Lee MA; Lopez AF
    Exp Hematol; 2002 Oct; 30(10):1124-31. PubMed ID: 12384142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells.
    Chan CH; Blazar BR; Eide CR; Kreitman RJ; Vallera DA
    Blood; 1995 Oct; 86(7):2732-40. PubMed ID: 7670112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.